CNJ HOLDINGS INC has a total of 19 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, Japan and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are BIOGEN IDEC HEMOPHILIA INC, ZYSTOR THERAPEUTICS INC and BIOGEN HEMOPHILIA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Japan | 3 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | Hong Kong | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Canada | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Israel | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Enzymes | |
#5 | Microorganisms | |
#6 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Griffith Michael J | 8 |
#2 | Johnstone Darrell | 8 |
#3 | George Joyee Antony | 6 |
#4 | Berry Jody | 6 |
#5 | Saward Laura | 5 |
#6 | Drohan William N | 5 |
#7 | Cassan Robyn | 5 |
#8 | Mankarious Samia | 2 |
#9 | Stafford Darrel W | 2 |
#10 | Taylor John R | 2 |
Publication | Filing date | Title |
---|---|---|
CN109776676A | For the antibody of clostridium difficile | |
AU2008245524A1 | Recombinant vitamin K dependent proteins with high sialic acid content and methods of preparing same |